Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
BioLife Solutions
BLFS
$1.57B
| $2.47M | ﹤0.01% |
151,131
-1,583
| -1% | -$21.8K |
|
|
QEP
2727
DELISTED
QEP RESOURCES, INC.
QEP
| $2.46M | ﹤0.01% |
1,908,426
-1,395,437
| -42% | -$1.3M |
|
2728
Immersion
IMMR
$248M
| $2.45M | ﹤0.01% |
393,228
-75,059
| -16% | -$484K |
|
2729
Vitamin Cottage Natural Grocers
NGVC
$765M
| $2.44M | ﹤0.01% |
164,162
-22
| -0% | -$268 |
|
2730
VEON
VEON
$3.68B
| $2.44M | ﹤0.01% |
54,273
+8,464
| +18% | +$340K |
|
|
PRVL
2731
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $2.44M | ﹤0.01% |
163,820
+8,856
| +6% | +$136K |
|
2732
Lakeland Industries
LAKE
$117M
| $2.44M | ﹤0.01% |
108,718
+45,195
| +71% | +$740K |
|
2733
Apyx Medical
APYX
$176M
| $2.43M | ﹤0.01% |
438,247
+22,734
| +5% | +$94.5K |
|
|
REVG
2734
DELISTED
REV Group
REVG
| $2.43M | ﹤0.01% |
398,715
+15,216
| +4% | +$81.7K |
|
2735
Daktronics
DAKT
$1,000M
| $2.43M | ﹤0.01% |
558,890
+23,136
| +4% | +$102K |
|
2736
LSI Industries
LYTS
$886M
| $2.43M | ﹤0.01% |
375,967
+177,007
| +89% | +$1.02M |
|
2737
Comstock Resources
CRK
$3.94B
| $2.43M | ﹤0.01% |
554,141
+336,899
| +155% | +$2.01M |
|
|
VWTR
2738
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $2.42M | ﹤0.01% |
287,725
+10,624
| +4% | +$85K |
|
2739
Rocky Brands
RCKY
$380M
| $2.42M | ﹤0.01% |
117,796
+3,512
| +3% | +$69.9K |
|
2740
Luxfer Holdings
LXFR
$459M
| $2.42M | ﹤0.01% |
170,889
+10,384
| +6% | +$143K |
|
2741
Fidelity D&D Bancorp
FDBC
$313M
| $2.42M | ﹤0.01% |
50,278
+10,830
| +27% | +$434K |
|
2742
Team
TISI
$77.7M
| $2.42M | ﹤0.01% |
43,383
+774
| +2% | +$42.8K |
|
|
AY
2743
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $2.4M | ﹤0.01% |
82,702
-6,394
| -7% | -$161K |
|
2744
Global Indemnity Group
GBLI
$402M
| $2.4M | ﹤0.01% |
100,386
+5,048
| +5% | +$121K |
|
|
KALV
2745
DELISTED
KalVista Pharmaceuticals
KALV
| $2.4M | ﹤0.01% |
198,285
+6,616
| +3% | +$70.4K |
|
2746
Pure Cycle
PCYO
$258M
| $2.39M | ﹤0.01% |
260,437
+8,544
| +3% | +$83.5K |
|
2747
Northrim BanCorp
NRIM
$606M
| $2.39M | ﹤0.01% |
379,824
+316
| +0.1% | +$1.83K |
|
|
GRFS
2748
Grifois
GRFS
$5.35B
| $2.38M | ﹤0.01% |
130,548
+361
| +0.3% | +$7.16K |
|
2749
Veru
VERU
$36.3M
| $2.38M | ﹤0.01% |
71,300
+32,543
| +84% | +$1.12M |
|
2750
Metallus
MTUS
$851M
| $2.37M | ﹤0.01% |
608,514
+50,503
| +9% | +$169K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.